HMP Global December 10, 2025
F. Randy Vogenberg, PhD, FASHP

INTRODUCTION

In the health plan year 2025, health care stakeholders faced the lingering effects of the COVID-19 pandemic, a change in presidential and congressional party leadership, and artificial intelli­gence (AI)’s growing integration in health care. In addition, the rapid growth of the GLP-1 drug category overshadowed the im­pact of biologic-based products, especially cancer therapeutics.

These market factors focused the attention of business leadership, human resource departments (HR), and company boardrooms beyond health care costs. Such dynamic changes in this marketplace—shifts in regulation or law and economic ramifications—require a more robust understanding of roles, responsibilities, and available time for all business sector leaders to sustain their business through 2025 into 2026.

This column will review health care...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Employer, Insurance, Patient / Consumer
Why cover GLP-1s? They’ll lower employer healthcare costs, study says
Small business health insurance coverage at risk as costs rise, EBRI finds
8 Values That Are Redefining The Workplace Of The Late 2020s
Employer Health Costs: Amid Continual Increases the Cost of Doing Nothing is Too High
Leadership, employee experience big issues for employers in 2026

Share Article